- Patent covers brilaroxazine use for treating Pulmonary Fibrosis -Similar patents have also been granted in key markets around the world including the United States, China, and Japan -Brilaroxazine has a novel mechanism of action for treating the underlying disruption in serotonin signaling implicated in the pathogenesis of Pulmonary Fibrosis CUPERTINO, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical com ...

Agreement outlines plans for one of the first domestic sources of battery-grade nickel carbonateRENO, Nev., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable battery metals recycling and refining, today announced a non-binding Letter of Intent (LOI) with Westwin Elements, America’s only major nickel refinery, outlining plans for the potential to supply by Aqua Metals up to 1,000 metric tons of recycled nickel carbonate annually to Westwin Elements. At current nicke ...

Third Quarter 2025 Revenue of $30.3 million; Net Income of $17.0 millionOMAHA, Neb., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (NYSE American: EXOD) ("Exodus"), a leading self-custodial cryptocurrency platform, today announced its unaudited results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights (Unaudited) In USD millions, except percentagesQ3 2025Q3 2024 % ChangeRevenue $30.3 $20.1 51%Technology, development and user support 17.0 11.3 50%General and ...

-Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions and simultaneously published in The New England Journal of Medicine- -CASGEVY® momentum accelerating; nearly 300 patients have been referred to Authorized Treatment Centers (ATCs), approximately 165 patients have completed their first cell collection and 39 have received infusions across all regions; Vertex expects clear line of sight to over $100 million in total CASGEVY ...

Nov 10, 2025 8:00 AM Eastern Standard Time KinderCare Announces Lindsay Sorhondo as New COO to Lead Next Phase of Growth Share LAKE OSWEGO, Ore.--(BUSINESS WIRE)--KinderCare Learning Companies, Inc.("KinderCare†), a leading provider of high-quality early childhood education, today announced the promotion of Chief Innovation Officer Lindsay Sorhondo to Chief Operating Officer, effective Nov. 11, 2025. Sorhondo will oversee the company's strategy, operations and growth channels, customer experience and insi ...

TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced the appointment of Sammy Dorf, Esq. to its Board of Directors. Sammy is a pioneering force in the modern cannabis economy and one of the industry’s most accomplished dealmakers, strategists, and growth architects. Most recently serving as Executive Chairman of Flora Growth Corp. (NASDAQ: FLGC), Sammy guided the company through a transformative phase marked by innovation, discipline ...

VANCOUVER, BC / ACCESS Newswire / November 10, 2025 / SKY GOLD CORP. ("Sky" or the "Company") (TSX.V:SKYG)(US:SRKZF) is pleased to announce that drilling has commenced at the Company's flagship Evening Star property, located in the prolific Walker Lane Gold Trend in Nevada. ...

New research identifies the "growth tax" on companies due to enterprise software-induced complexity, which drains millions of dollars and costs employees nearly a full workday each week in lost productivitySAN MATEO, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- As businesses expand their technology stacks and operational processes, they face a hidden but pervasive challenge: complexity. A new report from Freshworks Inc. (NASDAQ: FRSH) has calculated exactly what that complexity costs. The Cost of Complexity Re ...

EMERYVILLE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that Warner Biddle, Chief Executive Officer of Kyverna, will present at the Jefferies Global Healthcare Conference in London, United Kingdom on Monday, November 17, 2025 at 1:00 p.m. GMT. A live webcast of the presentation may be accessed via the Investors section of the ...

Twine and Henderson Are Innovating American Textile Manufacturing with Localized, Eco-Friendly, Same-Day Thread and Yarn Dyeing Production Rehovot, Israel, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Steakholder Foods Ltd. (Nasdaq: STKH), a leading innovator in alternative proteins and 3D printing technologies, announced today that its wholly-owned subsidiary, Twine Solutions, the Israeli pioneer of digital, waterless, on-demand thread and yarn dyeing technology, is strengthening its long-standing collaboration with ...